openPR Logo
Press release

United States Contraceptive Drugs Market | Regulatory Support, Growth Opportunities, Industry Outlook 2031 | Agile Therapeutics, Ansell Ltd, Mayer Laboratories Inc, Veru Inc

11-04-2025 07:58 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Credits of Image: https://www.gaals.com.au/

Credits of Image: https://www.gaals.com.au/

DataM Intelligence unveils its latest report on the "Contraceptive drugs Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/contraceptive-drugs-market?kb

Latest M&A in Contraceptive Drugs

Teva Pharmaceuticals acquired a majority stake in a European contraceptive manufacturer in 2023 to bolster its contraceptive portfolio and market presence in women's healthcare.

HRA Pharma (a Perrigo subsidiary) is expanding its reach with its OTC emergency contraceptive lines, responding to growing consumer demand for non-prescription options.

The contraceptives market is highly competitive and concentrated among multinational pharmaceutical companies focusing on innovation and geographic expansion.

List of Top Key Player:

Teva Pharmaceuticals, Merck & Co Inc, Agile Therapeutics, Ansell Ltd, Mayer Laboratories Inc, Veru Inc, Pfizer Inc, Bayer AG, Abbvie Inc and others.

Latest FDA Approvals Related to Contraceptive Drugs

FDA approved Miudella, a copper IUD, for contraception in February 2025 as a new device option.

Opill (norgestrel) oral contraceptive tablet obtained FDA approval in 2023 for nonprescription use, marking the first daily oral contraceptive for over-the-counter sale.

Several novel contraceptive drugs and male contraception options are in clinical trials, with the male pill YCT-529 recently passing human safety testing in 2025.

Forecast Projection:

The Global Contraceptive drugs Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.

Market Intelligence Research Process:

The Contraceptive drugs Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/buy-now-page?report=contraceptive-drugs-market?kb

Key Segmentation:

By Type: (Oral Contraceptive Pills, Topical Contraceptive Patch, Contraceptive Injectables)

By Distribution Channel: (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Global Growth Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Reimbursement Landscape for Contraceptives

In countries like the Netherlands, contraceptive pills, injections, spirals (IUCDs), hormonal patches, and rings are reimbursed under public healthcare insurance primarily for women under 21 or for medical necessity.

Supplemental insurance plans often provide partial reimbursement up to specific annual limits, whereas costs related to device insertion are generally non-reimbursed.

In the U.S., health plans typically cover 12-month refills of contraceptive drugs including oral, transdermal, and intravaginal hormonal options, aligned with clinical guidelines to maximize access.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/contraceptive-drugs-market?kb

FAQ's

Q1: How large is the Contraceptive drugs Market?

Ans: The Contraceptive drugs Market size was valued at USD$ 13.6 billion in 2022 and is projected to grow to USD $ 22.4 billion by 2031

Q2: How quickly is the Contraceptive drugs Market expanding?

Ans: The Contraceptive drugs Market is forecasted to grow at a CAGR of 6.6% between 2024 and 2031, showing strong growth momentum

Q3: Which regions are dominating the Contraceptive drugs Market and which are fastest-growing?

Ans: North America dominating the Contraceptive drugs market.

Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/contraceptive-drugs-market?kb

Drugs Related to Contraceptive Use

Leading pharmaceutical companies like Bayer AG dominate the market with flagship oral contraceptive pills such as Yasmin.

Emerging products include emergency contraceptive pills, hormone-free male contraceptives, and long-acting reversible contraceptives (LARCs) to widen contraceptive choices.

Teva, Pfizer, and Johnson & Johnson remain key players launching next-generation low-dose formulations and innovative contraceptive lines.

Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Contraceptive Drugs Market | Regulatory Support, Growth Opportunities, Industry Outlook 2031 | Agile Therapeutics, Ansell Ltd, Mayer Laboratories Inc, Veru Inc here

News-ID: 4252386 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Breakthrough Nutritional Ingredients Poised to Capture USD 325.4 Billion by 2031, Driven by Supplements and Functional Foods Demand | DataM Intelligence
Breakthrough Nutritional Ingredients Poised to Capture USD 325.4 Billion by 2031 …
The Global Nutritional Ingredients Market was valued at USD 182.5 billion in 2022 and is projected to reach USD 325.4 billion by 2031, growing at a CAGR of 7.5% during the forecast period 2024-2031. This robust growth is driven by a profound and global consumer shift towards health and wellness, the accelerating adoption of vegan and plant-based lifestyles, an aging global population seeking preventative nutrition, and the rapid expansion of
United States Aluminum Powder Market to Hit $3.71 Billion by 2032 | Leading companies - Toyal America Inc, Hunan Ningxiang Jiweixin Metal Powder Co., Ltd., ECKA Granules
United States Aluminum Powder Market to Hit $3.71 Billion by 2032 | Leading comp …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" Global Aluminum Powder Market Size reached US$ 7.32 billion in 2024 and is expected to reach US$ 12.39 billion by 2032, growing with a CAGR of 6.80% during the forecast period 2025-2032." Lightweight materials demand and additive manufacturing growth are boosting aluminum powder usage. Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/aluminum-powder-market?Prasad United States: Recent Industry
North America Non-Steroidal Anti-Inflammatory Drugs Market to Reach $17.27 Billion by 2033 | Leading companies - Bayer AG, Haleon group of companies, Kenvue, Teva Pharmaceutical Industries Ltd
North America Non-Steroidal Anti-Inflammatory Drugs Market to Reach $17.27 Billi …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" The North America non-steroidal anti-inflammatory drugs market size reached US$ 8.34 billion in 2024 and is expected to reach US$ 17.27 billion by 2033, growing at a CAGR of 7.6% during the forecast period 2025-2033." Chronic pain prevalence and OTC self-care trends continue to strengthen the NSAIDs market. Download your exclusive sample report today: (corporate email gets priority access):
United States Gene Therapy Market to Hit $6510.45 Million by 2033 | Leading companies - Alnylam Pharmaceuticals, Inc., NOVARTIS AG, Sarepta Therapeutics, Inc.
United States Gene Therapy Market to Hit $6510.45 Million by 2033 | Leading comp …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" The US Gene Therapy Market Size reached US$ 2,812.92 million in 2024 and is expected to reach US$ 21,701.51 million by 2033, growing at a CAGR of 23.5 % during the forecast period 2025-2033." Advances in viral vectors and precision medicine are driving rapid progress in the US gene therapy market. Download your exclusive sample report today: (corporate

All 5 Releases


More Releases for Contraceptive

Prominent Contraceptive Devices Market Trend for 2025: Innovative Products In Th …
What industry-specific factors are fueling the growth of the contraceptive devices market? The rising prevalence of sexually transmitted diseases (STDs) is expected to fuel the growth of the contraceptive device market. STDs, influenced by increased sexual activity and insufficient protection, are on the rise, making contraceptive devices, especially condoms, essential for reducing transmission risks. The UK Health Security Agency reported a 4.7% increase in new STI diagnoses in England in 2023,
Contraceptive Devices Market - Revolutionizing Family Planning: Cutting-Edge Con …
Newark, New Castle, USA: The "Contraceptive Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Contraceptive Devices Market: https://www.growthplusreports.com/report/contraceptive-devices-market/7763 This latest report researches the industry structure, sales, revenue,
Contraceptive Drugs Market: Doctors on the cusp of launching the first male cont …
Contraceptive Drugs Market by Product (Oral Contraceptive Pills, Injectable Contraceptives, and Topical Contraceptives), Age Group (15-24 Years, 25-34 Years, 35-44 Years, and Above 44 Years), and End User (Homecare, Hospitals, and Clinics): Global Opportunity Analysis and Industry Forecast, 2020-2027. Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/9850 The global contraceptive drugs market size was evaluated at $14,324.12 million in 2019, and is estimated to garner $24,412.22 million by 2027, registering a CAGR of 6.9% during
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones
Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones